ArticleInvestigational new drugs2012

Nutlin-3 differentially modulates miRNA34a and miRNA181 versus miR26a and miR155 in p53 proficient and p53 deficient B chronic lymphocytic leukemia (B-CLL) samples.

Maria Grazia di Iasio et al.PubMed ↗Publisher ↗

No numbers read from the abstract.